Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03797326
Brief Title: Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

First Submitted : January 7, 2019
First Submitted that Met QC Criteria : January 7, 2019
First Posted : January 9, 2019

Last Update Submitted that Met QC Criteria : March 22, 2019
Last Update Posted : March 25, 2019 (Estimate)